The FX & rates outlook in 2021: may the FX be with you

18 February 2021

Ross WalkerChief UK Economist

View bio

Paul RobsonHead of G10 FX Strategy

View bio

Brian DaingerfieldHead of G10 FX Strategy

View bio

Other insights

View more insights

6 minute read

This saga may not feature lightsabres, wookies, or other heavily trademarked creations, but as our specialists explain in this feature, the FX & rates outlook for 2021 promises to be just as exciting as the classic Star Wars trilogy (at least, we think so).

A long time ago, in a galaxy far, far away, a loose global alliance of governments, central banks and public health authorities continued their battle against a ferocious pandemic in a bid to restore economic growth.

Key takeaways

  • A new hope for the UK economy: good vaccination pace, the completion of an UK-EU trade agreement, and economic resilience will likely push Sterling higher – but limited progress on new trade deals and coronavirus-related scarring could undermine the currency.
  • The pandemic strikes back in Europe: a comparatively slow vaccine rollout and strengthened lockdowns could weigh on the Euro and regional growth, but questions remain around the longevity of those trends.
  • Return of the Fed eye – and US fiscal stimulus: the Fed is unlikely to taper asset purchases until it sees improvements for the most vulnerable, and with large-scale fiscal stimulus now more likely after a Biden victory, we see US dollar weakness remaining a key theme.

A new hope: vaccines, Brexit & economic resilience support Sterling

While we don’t yet have full-year numbers, it’s clear 2020 saw an unprecedented fall in UK growth (we estimate -10% of gross domestic product, or GDP), materially worse than what was seen in the US and slightly larger than declines in the Euro area.

But the good news is that a recovery from that low base, even if delayed until the spring due to further lockdowns in Q1, means the UK should be able to achieve impressive growth rates as we move through the year – as vaccination momentum builds, lockdowns ease, and households put some of their extra cash to work (we estimate 3.7% and 7% GDP growth in 2021 and 2022, respectively). All of this should be broadly supportive of Sterling in the medium-term (especially with the window for negative interest rates in the UK now firmly shut).

Recent data lend further reason for optimism:

  • Monthly growth for November showed a less severe fall than expected: once the most heavily affected sectors are stripped out (hospitality, leisure, retail), service sector declines were relatively modest (especially compared with previous lockdowns), pointing to more resilience than we initially thought.
  • Labour market data for December showed a rise in the number of employees for the first time since the pandemic began: while it may be too soon to say whether this is a pivotal turning point, the fact that there weren’t further declines should lead to greater optimism.
  • Inflation remains low: we will likely see that step-up with the scheduled reversal of the VAT cut in April, and energy price base effects – the UK’s energy regulator, Ofgem, was aggressive with price caps last year, but those should ease in 2021.

At the same time, the UK-EU Brexit trade deal secured over Christmas, though perhaps not as comprehensive as some had initially hoped, will nevertheless help ease politics & media-driven market jitters that punctuated Sterling movements in the years preceding the agreement. Because of that, we think the risk premium will be lower going forward – in other words, investors will accept a lower Sterling exchange rate to compensate for greater certainty around the outlook.

However, if Brexit-related concerns do persist – particularly if the trade balance comes under pressure due to limited further trade deal progress – and if coronavirus-related scarring is more severe than estimated, that could undermine the currency in the long-term.

The pandemic strikes back: vaccine hiccups could weigh on the Euro

In the UK and elsewhere, the vaccine rollout is the key driver of the economic & FX outlook. The UK government has raised vaccine expectations – and appears to be meeting them. Some of this is supportive of Sterling because the UK was quick off the blocks, but also because the UK was among the hardest hit by the pandemic, so it’s safe to expect equal sensitivity to vaccine movements going forward – in the UK and elsewhere.

That said, vaccine supply hiccups and newly strengthened lockdowns in Europe have weighed on the Euro and cloud the medium-term economic outlook in the region. We think some of media & market pessimism here may be overblown, but beyond the headlines, Sterling-Euro pricing will fundamentally hinge on a recovery in Europe – so it’s worth looking out for possible distortions to the shape of that recovery.

Relative growth will be a key rate driver. We think Sterling-Euro could hit 1.15 or higher as the year progresses, depending on the extent to which the pandemic strikes back. Sterling-US Dollar could drift up to 1.40 and stay there for much of the year – partly due to a stronger pound and partly a weaker dollar. But where the rate lands will ultimately depend on relative growth in both countries, the speed of the vaccine rollout, and whether the Fed changes its outlook & approach to pandemic support.

Return of the Fed eye (and US fiscal stimulus): dollar outlook hinges on official support & global economic recovery

In the last two months of 2020, the US dollar weakened significantly – mostly due to negative vaccine news and investors’ defensive positioning against a surprise US presidential election outcome (a Trump victory).

But with the election out of the way (including a Senate run-off in January that handed the Democrats a razor-thin majority) and more progress on the vaccine front, the dollar has begun to strengthen and interest rates at the long end of the US Treasury yield curve rose – raising questions about whether the Fed would start to pull back from its quantitative easing (QE) programme.

The question on everyone’s mind for 2021 is: how long will the combination of a stronger dollar and higher interest rates last? We think it’s too early to abandon the view that the dollar will continue to weaken, for several reasons:

  • A Biden victory significantly increases the odds of large-scale fiscal stimulus: as we’ve written elsewhere, an initial support package of $1.9 trillion has been proposed, though we think a figure closer to $1-1.5 trillion is more realistic (but still substantial).
  • The Fed’s unlikely to taper asset purchases any time soon: its mandate includes both inflation and employment, and Fed Chair Powell has made it clear financial conditions will remain easy until they see more sustained improvement on the latter – particularly for low-wage workers, who have been hit the hardest by the pandemic (in January, we saw the first decline in non-farm payroll since April 2020). We expect the Fed to keep a close eye on how the pandemic affects the most vulnerable.
  • The dollar’s status as a global safe haven means a stronger US economy doesn’t necessarily equal a stronger currency: much like what’s been said about Europe and the UK, that vaccine progress helps service-oriented economies recover more quickly (and catch up with manufacturing-oriented economies) certainly holds true for the US. But the dollar’s supremacy in global trade & commerce means a stronger US economy could be of greater benefit in the near-term to smaller, growth-oriented economies (and their currencies), and may not necessarily lead to strengthening if it isn’t accompanied by a broad-based global recovery.

There may be near-term challenges to our dollar view – the path of interest rates, fiscal stimulus, investor positioning, and more recently, concern from other central banks about strength of their own currencies – but we still see a weaker dollar on the horizon.

Check out our Year Ahead Hub to read more analysis on the key themes moving markets this year, or to visit our The Foreign Exchange (FX) Markets Insights Hub to keep up-to-date with the latest views from the FX Market.

Fixed Income
Monetary Policy

This document has been prepared for information purposes only, does not constitute an analysis of all potentially material issues and is subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes.  It is indicative only and is not binding. Other than as indicated, this document has been prepared on the basis of publicly available information believed to be reliable but no representation, warranty, undertaking or assurance of any kind, express or implied, is made as to the adequacy, accuracy, completeness or reasonableness of the information contained in this document, nor does NatWest Markets accept any obligation to any recipient to update or correct any information contained herein. Views expressed herein are not intended to be and should not be viewed as advice or as a personal recommendation. The views expressed herein may not be objective or independent of the interests of the authors or other NatWest Markets trading desks, who may be active participants in the markets, investments or strategies referred to in this document. NatWest Markets will not act and has not acted as your legal, tax, regulatory, accounting or investment adviser; nor does NatWest Markets owe any fiduciary duties to you in connection with this, and/or any related transaction and no reliance may be placed on NatWest Markets for investment advice or recommendations of any sort. You should make your own independent evaluation of the relevance and adequacy of the information contained in this document and any issues that are of concern to you.

This document does not constitute an offer to buy or sell, or a solicitation of an offer to buy or sell any investment, nor does it constitute an offer to provide any products or services that are capable of acceptance to form a contract. NatWest Markets and each of its respective affiliates accepts no liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this material or reliance on the information contained herein. However this shall not restrict, exclude or limit any duty or liability to any person under any applicable laws or regulations of any jurisdiction which may not be lawfully disclaimed.

NatWest Markets Plc. Incorporated and registered in Scotland No. 90312 with limited liability. Registered Office: 36 St Andrew Square, Edinburgh EH2 2YB. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority. NatWest Markets N.V. is incorporated with limited liability in the Netherlands, authorised and regulated by De Nederlandsche Bank and the Autoriteit Financiële Markten. It has its seat at Amsterdam, the Netherlands, and is registered in the Commercial Register under number 33002587. Registered Office: Claude Debussylaan 94, Amsterdam, the Netherlands. Branch Reg No. in England BR001029. NatWest Markets Plc is, in certain jurisdictions, an authorised agent of NatWest Markets N.V. and NatWest Markets N.V. is, in certain jurisdictions, an authorised agent of NatWest Markets Plc. NatWest Markets Securities Japan Limited [Kanto Financial Bureau (Kin-sho) No. 202] is authorised and regulated by the Japan Financial Services Agency. Securities business in the United States is conducted through NatWest Markets Securities Inc., a FINRA registered broker-dealer (, a SIPC member ( and a wholly owned indirect subsidiary of NatWest Markets Plc.

Copyright 2020 © NatWest Markets Plc. All rights reserved.